BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 26755811)

  • 1. Hepatorenal syndrome in hospitalized patients with chronic liver disease: results from the Nationwide Inpatient Sample 2002-2012.
    Pant C; Jani BS; Desai M; Deshpande A; Pandya P; Taylor R; Gilroy R; Olyaee M
    J Investig Med; 2016 Jan; 64(1):33-8. PubMed ID: 26755811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults.
    Hirode G; Saab S; Wong RJ
    JAMA Netw Open; 2020 Apr; 3(4):e201997. PubMed ID: 32239220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatorenal syndrome: a Nationwide Trend Analysis from 2008 to 2018.
    Singh J; Dahiya DS; Kichloo A; Singh G; Khoshbin K; Shaka H
    Ann Med; 2021 Dec; 53(1):2018-2024. PubMed ID: 34985399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary Trends in Hospitalizations for Comorbid Chronic Liver Disease and Substance Use Disorders.
    Desai AP; Greene M; Nephew LD; Orman ES; Ghabril M; Chalasani N; Menachemi N
    Clin Transl Gastroenterol; 2021 Jun; 12(6):e00372. PubMed ID: 34142663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare burden and outcomes of hepatorenal syndrome among cirrhosis-related hospitalisations in the US.
    Singal AK; Kuo YF; Reddy KR; Bataller R; Kwo P
    Aliment Pharmacol Ther; 2022 Nov; 56(10):1486-1496. PubMed ID: 36196562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes among patients with hepatorenal syndrome based on hospital teaching and transplant status: Analysis of 159 845 hospitalizations.
    Sohal A; Chaudhry H; Dukovic D; Kowdley KV
    JGH Open; 2023 Dec; 7(12):848-854. PubMed ID: 38162842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term clinical outcomes of patients admitted with chronic liver disease to selected teaching hospitals in Ethiopia.
    Terefe Tesfaye B; Gudina EK; Bosho DD; Mega TA
    PLoS One; 2019; 14(8):e0221806. PubMed ID: 31469861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune Hepatitis and Obstetrical Outcomes: A Nationwide Assessment.
    Kilani Y; Arshad I; Aldiabat M; Bhatija RR; Alsakarneh S; Yazan A; Ebhohon E; Vikash F; Kumar V; Kamal SAF; Castro Puello P; Numan L; Kassab M
    Dig Dis Sci; 2023 Dec; 68(12):4389-4397. PubMed ID: 37815688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Liver Disease and Cirrhosis are Associated with Worse Outcomes Following SARS-CoV-2 Infection.
    Wong RJ; Zhang Y; Thamer M
    J Clin Exp Hepatol; 2023; 13(4):592-600. PubMed ID: 36777086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing the utility of renal replacement therapy to manage hepatorenal syndrome in alcoholic hepatitis without liver transplantation: a nationwide analysis.
    Farooq U; Tarar ZI; El Alayli A; Kamal F; Niu C; Qureshi K
    J Gastroenterol Hepatol; 2024 Mar; 39(3):560-567. PubMed ID: 37953474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical care outcomes in decompensated cirrhosis: a United States national inpatient sample cross-sectional study.
    Goble SR; Ismail AS; Debes JD; Leventhal TM
    Crit Care; 2024 May; 28(1):150. PubMed ID: 38715040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Race and Sex on the Clinical Outcomes of Homeless Patients With Alcoholic Liver Disease: Propensity Score Matched Analysis of US Hospitals.
    Lee DU; Kwon J; Han J; Chang K; Kolachana S; Bahadur A; Lee KJ; Fan GH; Malik R
    J Clin Gastroenterol; 2023 Oct; ():. PubMed ID: 37983807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis A hospitalisations in the United States and risk factors for inpatient mortality: A nationwide population study, 1998-2020.
    Wasuwanich P; So JM; Rajborirug S; Karnsakul W
    J Viral Hepat; 2024 Feb; 31(2):88-95. PubMed ID: 38062864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute blood loss anemia in hospitalized patients is associated with adverse outcomes: An analysis of the Nationwide Inpatient Sample.
    Dasarathy D; Attaway AH
    Am J Med Sci; 2024 Apr; 367(4):243-250. PubMed ID: 38185404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-Preventable Illness Leads to Adverse Outcomes in Liver Transplant Recipients.
    Sohal A; Kohli I; Chaudhry H; Singh I; Arora K; Kalra S; Dukovic D; Roytman M
    Dig Dis Sci; 2024 Feb; 69(2):588-595. PubMed ID: 38030833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Stroke in Patients With Chronic Liver Disease: A Practical Review.
    Parikh NS; Basu E; Hwang MJ; Rosenblatt R; VanWagner LB; Lim HI; Murthy SB; Kamel H
    Stroke; 2023 Sep; 54(9):2461-2471. PubMed ID: 37417238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-Based Therapeutic Options for Hepatorenal Syndrome.
    Glass L; Sharma P
    Gastroenterology; 2016 Apr; 150(4):1031-3. PubMed ID: 26922867
    [No Abstract]   [Full Text] [Related]  

  • 18. Which Factors are Predictive for Mortality among Hospitalized Patients with Cirrhosis?
    Uslan I; Olt S; Eminler AT
    Hepatogastroenterology; 2015 Jun; 62(140):1023-6. PubMed ID: 26902049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome.
    Amin AA; Alabsawy EI; Jalan R; Davenport A
    Semin Nephrol; 2019 Jan; 39(1):17-30. PubMed ID: 30606404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving Outcomes in Hepatorenal Syndrome-Acute Kidney Injury With Early Diagnoses and Implementation of Approved Treatment Regimens.
    Pyrsopoulos NT; Bernstein D; Kugelmas M; Owen EJ; Reddy KR; Reau N; Saab S; Wadei HM
    Gastroenterol Hepatol (N Y); 2023 Dec; 19(12 Suppl 7):3-13. PubMed ID: 38444690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.